3.0 Read 2 reviews
Overview
What you will learn
By taking the Structured benefit-risk assessment of medicinal products course offered by Elevate Academy , you will learn to:
- Recognize the complexity of a benefit risk comparison.
- Familiarize with structured decision making.
- Describe how patient perspectives are incorporated in regulatory decision making.
- Design an effects table.
- Recognize the different steps in a decision aiding process by means of a structured benefit-risk assessment.
- Describe what factors are involved in benefit-risk comparison.
- Describe how complex decision problems can be addressed and resolved through the specification of value trade-offs.
- Describe and interpret the two components of the additive value model (i.e., the weights and the partial value functions).
- Describe how clinical data on efficacy and safety can be combined with an elicited value function to perform a quantitative benefit-risk assessment (qBRA).
- Describe how stochastic multi-criteria acceptability analysis can be applied to account for uncertainty in the data and imprecision in the preferences.
Programme Structure
The program focuses on:
- Benefit-Risk Assessment
- Decision Making Styles
- Multiple-criteria Decision Analysis
- Final Assignment
Key information
Duration
- Part-time
- 1 days
Start dates & application deadlines
You can apply for and start this programme anytime.
Language
English
Delivered
Online
- Self-paced
Disciplines
Medicine Risk Management View 9 other Short Courses in Medicine in NetherlandsAcademic requirements
We are not aware of any specific GRE, GMAT or GPA grading score requirements for this programme.
English requirements
We are not aware of any English requirements for this programme.
Other requirements
General requirements
- Participants distributed over the whole medicine development chain: from academic researchers to industry, regulatory and other professionals.
- No diplomas are required for enrollment, but the course is aimed at participants who have an advanced level of understanding of benefit-risk in drug development. Familiarity with regulatory science and medicines development is recommended.
- The course will be taught in English. To successfully participate, sufficient proficiency in English reading and writing is required.
Tuition Fee
To always see correct tuition fees
-
International
1100 EUR/fullTuition FeeBased on the tuition of 1100 EUR for the full programme during 1 days. -
National
1100 EUR/fullTuition FeeBased on the tuition of 1100 EUR for the full programme during 1 days.
Funding
Improve page content